This Program-Project Grant has as its goal and underlying them a better understanding of the biochemical and genetic mechanisms involved in the development of neoplasia induced by chemical carcinogens. Each of the projects is directed by one of the co-investigators of this grant, and each project will individually contribute to a greater under of an important aspect of the mechanisms in chemical carcinogenesis. While the individual projects are distinct, the interactions and sharing of specific expertise by the co-investigators serve to dramatically enhance the potential productivity of the group. Dr. Bradfield's group is involved in studying the genetic toxicology of the Ah locus and its interacting genes utilizing gene targeting technologies. Dr. Drinkwater is elucidating the genetic and hormonal factors involved in the stage of promotion during murine hepatocarcinogenesis. The objective of Dr. Fahl's research is to understand the mechanisms of the expression of specific glutathione S- transferase genes and their role in the resistance of cells to toxic and carcinogenic xenobiotics. Dr. Farnham's group is concerned with the role of the E2F family of transcription factors in the processes of liver regeneration and chemically-induced hepatocellular carcinogenesis in the mouse. Dr. Kasper seeks to understand structure-function relationships in specific members of the mixed-function oxidase system and to determine how individual components are related to xenobiotic metabolism and the overall function of the organism. Dr. Pitot's group has concerned itself primarily with an understanding of the biochemical and genetic mechanisms involved in the transition of hepatocytes from the stage of promotion to the stage of progression in the appearance of malignant neoplasia in rat liver. All of these projects will contribute to our knowledge of the chemical mediation of carcinogenesis. Extensive epidemiologic evidence has attested to the critical importance of the induction of cancer in the human by environmental and endogenous chemicals, e.g., smoking, diet, hormones, alcohol, and other drugs. Our ultimate understanding of the mechanisms by which such chemical induce cancer in the human is the long-term goal of the studies of this Program-Project Grant.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA022484-25
Application #
6497585
Study Section
Subcommittee G - Education (NCI)
Program Officer
Yang, Shen K
Project Start
1978-04-01
Project End
2004-01-31
Budget Start
2002-02-01
Budget End
2004-01-31
Support Year
25
Fiscal Year
2002
Total Cost
$2,221,541
Indirect Cost
Name
University of Wisconsin Madison
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Xia, Chuanwu; Rwere, Freeborn; Im, Sangchoul et al. (2018) Structural and Kinetic Studies of Asp632 Mutants and Fully Reduced NADPH-Cytochrome P450 Oxidoreductase Define the Role of Asp632 Loop Dynamics in the Control of NADPH Binding and Hydride Transfer. Biochemistry 57:945-962
Oberley, Christopher C; Bilger, Andrea; Drinkwater, Norman R (2015) Genetic background determines if Stat5b suppresses or enhances murine hepatocarcinogenesis. Mol Carcinog 54:959-70
Kennedy, Gregory D; Nukaya, Manabu; Moran, Susan M et al. (2014) Liver tumor promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin is dependent on the aryl hydrocarbon receptor and TNF/IL-1 receptors. Toxicol Sci 140:135-43
Copp, Richard R; Peebles, Daniel D; Soref, Cheryl M et al. (2013) Radioprotective efficacy and toxicity of a new family of aminothiol analogs. Int J Radiat Biol 89:485-92
Figueiredo, Marxa L; Stein, Timothy J; Jochem, Adam et al. (2012) Mutant Hras(G12V) and Kras(G12D) have overlapping, but non-identical effects on hepatocyte growth and transformation frequency in transgenic mice. Liver Int 32:582-91
Stein, Timothy J; Jochem, Adam; Holmes, Katie E et al. (2011) Effect of mutant ?-catenin on liver growth homeostasis and hepatocarcinogenesis in transgenic mice. Liver Int 31:303-12
Copp, Richard R; Peebles, Daniel D; Fahl, William E (2011) Synthesis and growth regulatory activity of a prototype member of a new family of aminothiol radioprotectors. Bioorg Med Chem Lett 21:7426-30
Stein, Timothy J; Bowden, Margaret; Sandgren, Eric P (2011) Minimal cooperation between mutant Hras and c-myc or TGF? in the regulation of mouse hepatocyte growth or transformation in vivo. Liver Int 31:1298-305
Xia, Chuanwu; Hamdane, Djemel; Shen, Anna L et al. (2011) Conformational changes of NADPH-cytochrome P450 oxidoreductase are essential for catalysis and cofactor binding. J Biol Chem 286:16246-60
Figueiredo, Marxa L; Wentworth, Kristin M; Sandgren, Eric P (2010) Quantifying growth and transformation frequency of oncogene-expressing mouse hepatocytes in vivo. Hepatology 52:634-43

Showing the most recent 10 out of 258 publications